TITLE

Benchmarking Human Protein Complexes to Investigate Drug-Related Systems and Evaluate Predicted Protein Complexes

AUTHOR(S)
Wu, Min; Yu, Qi; Li, Xiaoli; Zheng, Jie; Huang, Jing-Fei; Kwoh, Chee-Keong
PUB. DATE
February 2013
SOURCE
PLoS ONE;Feb2013, Vol. 8 Issue 2, p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Protein complexes are key entities to perform cellular functions. Human diseases are also revealed to associate with some specific human protein complexes. In fact, human protein complexes are widely used for protein function annotation, inference of human protein interactome, disease gene prediction, and so on. Therefore, it is highly desired to build an up-to-date catalogue of human complexes to support the research in these applications. Protein complexes from different databases are as expected to be highly redundant. In this paper, we designed a set of concise operations to compile these redundant human complexes and built a comprehensive catalogue called CHPC2012 (Catalogue of Human Protein Complexes). CHPC2012 achieves a higher coverage for proteins and protein complexes than those individual databases. It is also verified to be a set of complexes with high quality as its co-complex protein associations have a high overlap with protein-protein interactions (PPI) in various existing PPI databases. We demonstrated two distinct applications of CHPC2012, that is, investigating the relationship between protein complexes and drug-related systems and evaluating the quality of predicted protein complexes. In particular, CHPC2012 provides more insights into drug development. For instance, proteins involved in multiple complexes (the overlapping proteins) are potential drug targets; the drug-complex network is utilized to investigate multi-target drugs and drug-drug interactions; and the disease-specific complex-drug networks will provide new clues for drug repositioning. With this up-to-date reference set of human protein complexes, we believe that the CHPC2012 catalogue is able to enhance the studies for protein interactions, protein functions, human diseases, drugs, and related fields of research. CHPC2012 complexes can be downloaded from http://www1.i2r.a-star.edu.sg/xlli/CHPC2012/CHPC2012.htm.
ACCESSION #
87623414

 

Related Articles

  • Adding Diverse Noncanonical Backbones to Rosetta: Enabling Peptidomimetic Design. Drew, Kevin; Renfrew, P. Douglas; Craven, Timothy W.; Butterfoss, Glenn L.; Chou, Fang-Chieh; Lyskov, Sergey; Bullock, Brooke N.; Watkins, Andrew; Labonte, Jason W.; Pacella, Michael; Kilambi, Krishna Praneeth; Leaver-Fay, Andrew; Kuhlman, Brian; Gray, Jeffrey J.; Bradley, Philip; Kirshenbaum, Kent; Arora, Paramjit S.; Das, Rhiju; Bonneau, Richard // PLoS ONE;Jul2013, Vol. 8 Issue 7, p1 

    Peptidomimetics are classes of molecules that mimic structural and functional attributes of polypeptides. Peptidomimetic oligomers can frequently be synthesized using efficient solid phase synthesis procedures similar to peptide synthesis. Conformationally ordered peptidomimetic oligomers are...

  • PriaXplore® - a novel technology platform for the identification of small molecule modulators of protein-protein interactions. Eyrisch, Susanne; Girschick, Tobias; Ross, Günter; Kalinski, Cédric; Khazak, Vladimir; Weber, Lutz // Journal of Cheminformatics;2013, Vol. 5 Issue S1, p1 

    A conference paper about the development of PriaXplore®, a novel technology platform for the identification of small molecule modulators of protein-protein interactions (PPIs) is presented. It informs that the protein-protein interactions are broadly recognized as an emerging target class for...

  • Predicting residue–residue contacts using random forest models. Li, Yunqi; Fang, Yaping; Fang, Jianwen // Bioinformatics;Dec2011, Vol. 27 Issue 24, p3379 

    Motivation: Protein residue–residue contact prediction can be useful in predicting protein 3D structures. Current algorithms for such a purpose leave room for improvement.Results: We develop ProC_S3, a set of Random Forest algorithm-based models, for predicting residue–residue...

  • Network Propagation with Dual Flow for Gene Prioritization. Wu, Shunyao; Shao, Fengjing; Ji, Jun; Sun, Rencheng; Dong, Rizhuang; Zhou, Yuanke; Xu, Shaojie; Sui, Yi; Hu, Jianlong // PLoS ONE;Feb2015, Vol. 10 Issue 2, p1 

    Based on the hypothesis that the neighbors of disease genes trend to cause similar diseases, network-based methods for disease prediction have received increasing attention. Taking full advantage of network structure, the performance of global distance measurements is generally superior to local...

  • Structural and Energetic Characterization of the Ankyrin Repeat Protein Family. Parra, R. Gonzalo; Espada, Rocío; Verstraete, Nina; Ferreiro, Diego U. // PLoS Computational Biology;12/21/2015, Vol. 11 Issue 12, p1 

    Ankyrin repeat containing proteins are one of the most abundant solenoid folds. Usually implicated in specific protein-protein interactions, these proteins are readily amenable for design, with promising biotechnological and biomedical applications. Studying repeat protein families presents...

  • Network Topology Reveals Key Cardiovascular Disease Genes. Sarajlić, Anida; Janjić, Vuk; Stojković, Neda; Radak, Djordje; Pržulj, Nataša // PLoS ONE;Aug2013, Vol. 8 Issue 8, p1 

    The structure of protein-protein interaction (PPI) networks has already been successfully used as a source of new biological information. Even though cardiovascular diseases (CVDs) are a major global cause of death, many CVD genes still await discovery. We explore ways to utilize the structure...

  • G Protein �? Subunits as Targets for Small Molecule Therapeutic Development. Smrcka, Alan V.; Lehmann, David M.; Dessal, Axel L. // Combinatorial Chemistry & High Throughput Screening;Jun2008, Vol. 11 Issue 5, p382 

    G proteins mediate the action of G protein coupled receptors (GPCRs), a major target of current pharmaceuticals and a major target of interest in future drug development. Most pharmaceutical interest has been in the development of selective GPCR agonists and antagonists that activate or inhibit...

  • Protein-Protein Interaction Inhibition (2P2I): Fewer and Fewer Undruggable Targets. Betzi, Stéphane; Guerlesquin, Françoise; Morelli, Xavier // Combinatorial Chemistry & High Throughput Screening;Dec2009, Vol. 12 Issue 10, p968 

    Low molecular weight inhibitors of Protein-Protein Interactions (PPI's) have been identified for a nwater moumber of different systems indicating the viability of the computer-aided drug design approaches. However, pathways undertaken by researchers in pharmaceutical companies or in academic...

  • Targeting the hotspot of G-protein interactions. Harrison, Charlotte // Nature Reviews Drug Discovery;Jun2006, Vol. 5 Issue 6, p456 

    The article discusses the study made on g-protein interactions. G-protein interactions are found to be interesting drug targets but challenges on its topology and interaction surfaces has brought difficulties for progress. A region referred to as hot spots were considered in modulating the...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics